Companies: 10,795·Total market cap: $144.5T
Cyclerion Therapeutics, Inc.

Cyclerion Therapeutics, Inc.

CYCNNASDAQHealthcare● Active
$3.01
+$0.03(+1.01%)
Market Cap$13034233
P/E Ratio
52W High$8.48
52W Low$1.027

Cyclerion Therapeutics, Inc. (CYCN) Number of Employees – History & Annual Headcount

Annual SEC headcount, year-over-year change, and per-employee efficiency — chart and full history below.

SEC EDGAR · FMP · CYCN · as of Mar 4, 2025

Latest filing snapshot

200,000
+0+0.00%vs prior year

Cyclerion Therapeutics, Inc. (CYCN) employee data is sourced from the annual SEC 10-K filing. As of 2024, full-time employees only. Global consolidated headcount. View SEC filing

SEC 10-K·Period end: 2024-12-31·Full-time · Global
Total Employees
200,000
Change (1Y)
+0
Growth % (1Y)
+0.00%
Revenue / Employee
$10
Net Income / Employee
$-18
Market Cap
$13M

CYCN Employee Count

2019 – 2024 · Annual · SEC filing

Source: SEC annual filings · Hover bar to view year data · Click to view original filing

Employees History

Filing DateEmployeesChange (1Y)Growth (1Y)SEC filing link
2025-03-04200,000+0+0.00%
2024-03-05200,000+199,983+1176370.59%
2023-03-2217-15-46.88%
2022-02-2432-19-37.25%
2021-02-2551-43-45.74%
2020-03-1294

Source: SEC Annual Reports (Form 10-K / 20-F). Employee counts as of fiscal year end. Click the ↗ icon at the end of a row to open the original SEC filing in a new tab.

Related Companies — Employee Count

Biotechnology
#SymbolCompanyEmployees
#1
Cyclerion Therapeutics, Inc.
CYCN
Cyclerion Therapeutics, Inc.YOU
200,000
#2
AIM ImmunoTech Inc.
AIM
AIM ImmunoTech Inc.
21
#3
NovaBay Pharmaceuticals, Inc.
NBY
NovaBay Pharmaceuticals, Inc.
13
#4
Pasithea Therapeutics Corp.
KTTA
Pasithea Therapeutics Corp.
4
#5
Quoin Pharmaceuticals, Ltd.
QNRX
Quoin Pharmaceuticals, Ltd.
3
#6
Addex Therapeutics Ltd
ADXN
Addex Therapeutics Ltd
2
#7
Polyrizon Ltd.
PLRZ
Polyrizon Ltd.
2
Source: /stock-peers + /profile.fullTimeEmployees · Click row → /employees · Sorted by headcount · CYCN peer comparison

About CYCN employees

CYCN Employees · Headcount

Cyclerion Therapeutics, Inc. (CYCN) employee data is sourced from the annual SEC 10-K filing. As of 2024, Cyclerion Therapeutics, Inc. had 200,000 full-time employees globally. Full-time employees only. Global consolidated headcount.

Cyclerion Therapeutics, Inc. employs 200,000 full-time employees as of the latest filing within the Biotechnology industry. Revenue per employee stands at $10, reflecting the company's operational efficiency.

Cyclerion Therapeutics, Inc.'s workforce increased by 0 (0.00%) in 2024 compared to the prior fiscal year. The historical trend reflects the company's expansion and contraction cycles.

Cyclerion Therapeutics, Inc.'s revenue per employee of $10 positions it among the notable performers in the Biotechnology sector for operational efficiency.

Frequently Asked Questions

CYCN Employees · 5 questions

As of the latest SEC 10-K filing (2024), Cyclerion Therapeutics, Inc. had 200,000 full-time employees globally. This figure is sourced from the company's mandatory annual disclosure to the SEC.

Cyclerion Therapeutics, Inc. employee counthow many employees does Cyclerion Therapeutics, Inc. haveCYCN total employees 2024

Data source: FMP /historical-employee-count · SEC EDGAR annual filings · As reported · Global consolidated headcount · As of 2025-03-04